Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Chubb
Baxter
Fuji
Julphar
Chinese Patent Office
Novartis
Accenture
QuintilesIMS
Argus Health

Generated: December 12, 2017

DrugPatentWatch Database Preview

Meridian Medcl Company Profile

« Back to Dashboard

What is the competitive landscape for MERIDIAN MEDCL, and what generic alternatives to MERIDIAN MEDCL drugs are available?

MERIDIAN MEDCL has six approved drugs.

There is one US patent protecting MERIDIAN MEDCL drugs.

There are four patent family members on MERIDIAN MEDCL drugs in four countries.

Summary for Meridian Medcl

International Patents:4
US Patents:1
Tradenames:6
Ingredients:6
NDAs:6
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Meridian Medcl TechnATROPENatropineINJECTABLE;INJECTION017106-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Meridian MedclALSUMAsumatriptan succinateINJECTABLE;SUBCUTANEOUS022377-001Jun 29, 2010DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
Meridian Medcl TechnPRALIDOXIME CHLORIDEpralidoxime chlorideINJECTABLE;INJECTION018986-001Apr 26, 1983RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Meridian Medcl TechnATROPENatropineINJECTABLE;INJECTION017106-004Sep 17, 2004RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Meridian MedclDUODOTEatropine; pralidoxime chlorideINJECTABLE;INTRAMUSCULAR021983-001Sep 28, 2006RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Meridian Medcl TechnATROPENatropineINJECTABLE;INJECTION017106-003Jun 19, 2003RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Meridian Medcl TechnMORPHINE SULFATEmorphine sulfateINJECTABLE;INJECTION019999-001Jul 12, 1990RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Meridian Medcl TechnLIDOPENlidocaine hydrochlorideINJECTABLE;INJECTION017549-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Meridian Medcl TechnATROPENatropineINJECTABLE;INJECTION017106-002Jun 19, 2003RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Meridian Medcl

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Meridian MedclDUODOTEatropine; pralidoxime chlorideINJECTABLE;INTRAMUSCULAR021983-001Sep 28, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Meridian Medcl Drugs

Country Document Number Estimated Expiration
Canada2666860► Subscribe
World Intellectual Property Organization (WIPO)2008048750► Subscribe
European Patent Office2073866► Subscribe
Taiwan200838574► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Novartis
Healthtrust
Covington
Moodys
Harvard Business School
Citi
Cipla
Farmers Insurance
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot